OK so you thought the title of the other thread was out of date BUT unfortunately there is no way to edit thread titles.

So here is a new title

This one has got the charts at the top again & has a link to the old one.
http://www.moneyam.com/InvestorsRoom/posts.php?tid=5021

buy in on weakness

I am thinking along those lines hlyeo98 , but a seem to be buying a lot of longs at the moment ..

I spoke to Alan Kingsman by phone and got the same information as Martin. Not only did he confirm the email response above, but mentioned that the "Academic Group" that ran into a problem with its mice were trying to do something quite different and were, in effect, using "problematic mice" to start with

My take on my conversation with Alan Kingsman yesterday, in clarifying the scope of the GTAC notice (see MJC email above also) was that he sounded supremely confident - imo

Oh well, drifting down again.

I'm waiting for 16p to buy some more.

Let the guys behind the scenes get on with it, sp will eventually reflect their work and achievements.

16 you say apple , now that would be nice ..

Now at 18p

Looking at the one year graph above, is there any analysts out there who can explain this one. As this is a high risk stock, is this why no pattern has emerged.

Down another 5.5%

Still hoping for 16p to buy some more.

what is going on ???? we need some good news please

It will come eventually but I hope we reach 16p first.

why is the 16p mark so magical???

Because it's just about as low at it could get before a big upswing. I have been trading this co for yrs and the patterns are easily assessed. We are at that time now I believe before some more newsflow and a price hike so if you haven't got onboard, nows a good time. This is very very good value - soon this co will be re-rated around the 50p level and the potential is enormous. My best Bio! A cure for cancer is not long away i'm hoping, i'm actually very confident that OXB is the next Glaxo.

robstuff wrote: i'm actually very confident that OXB is the next Glaxo.

Hey easy on, thats a pretty strong statement but I like your style.

I bought at 18.5p back in oct 04 but may dabble again at the magical 16p mark.

Come on OXB bring us some festive cheer.

I bet Glaxo didn't keep it's holders waiting this long!!

In the early days, probably did. Could be a very strong performer in 05, there's plenty of news flow and the news could i believe be very exciting indeed. If just one of their products become commercial, this share will be worth 10times what it is now. We may have reached bottom today, the next trend upwards to 23 again.

It's turning , now hopefully back to mid twenties, get news and higher

A better day, Trading update due very soon, trials proceeding well as no news to the contrary, loads of cash, no reason to fall, charts show an upswing imminent, I have topped up for Xmas.

Results of Phase 2 trials for Trovax and Phase 2 of MetXia due any day, these are expected to be good and with a possible announcement that ProSavin will be going into trial and new licensing agreements for it's Lentivector Technology, the next couple of mths is going to be exciting for holders of OXB, i'd expect buying in anticipation of the news and possibly 30p in January, let's see...

robstuff - are you able to say where you got the info on pending results?